The previous two entries covered polyphenols and sulfur compounds—chemical weapons plants use for defense that become gentle activators of our own defenses. Plants use the alkaloids in this entry for something more aggressive: poisoning nerves directly.
Caffeine helps a coffee plant disable insects that feed on it. Nicotine is tobacco's natural insecticide. Capsaicin specifically discourages mammals from eating chili peppers [1-3]. All three act on the nervous system, with direct effects and narrower dosing windows. Alkaloids were never going to be uniformly good for us: some make useful everyday partners; others should be left completely alone.
The scoring system remains the same: 1–5 points each for effectiveness, safety, evidence, and everyday practicality, followed by an overall star rating and a green, yellow, or red tier. Food and supplement forms are separated only when their scores differ.
Caffeine: Mostly an Immediate-Performance Tool
The polyphenol entry reached a counterintuitive conclusion: the longevity association of coffee and tea is driven mainly by their polyphenols—chlorogenic acid and catechins—not caffeine. Remove the caffeine, and decaf retains nearly the same protective association 4.
So what is caffeine when we judge the molecule on its own?
Its main job is wakefulness. Caffeine resembles adenosine, the fatigue signal that accumulates the longer you stay awake. By occupying adenosine receptors, caffeine blocks that drowsiness signal and makes you feel alert 5. It also briefly stimulates the sympathetic nervous system, nudging blood pressure and vigilance upward, although resting heart rate usually does not rise with them 5.
That mechanism produces several well-established short-term benefits: greater alertness, faster reaction time, and modest improvements in endurance and strength when taken before exercise—which is why caffeine appears in most sports supplements 6,7. But the evidence becomes much thinner when we ask about long-term health or longevity. Most of that credit belongs to coffee's polyphenols 4,8.
Caffeine is a textbook hormetic molecule with a classic dose-response curve. A small dose sharpens focus; too much can bring anxiety, palpitations, tremor, and insomnia 7,9. Fortunately, it comes with a fairly obvious feedback system: drink too much, and your racing chest or sleepless night tells you. Use it as a tool for alertness or performance, but do not expect it to extend life—that is the polyphenol story. Caffeine also has a major effect on sleep, and excess intake may sit behind many people's sleep problems. We explained how to manage dose and timing in How to Drink Coffee Without Ruining Your Sleep, so I will not repeat the full protocol here. If you are caffeine-sensitive, anxious, have an arrhythmia, or are pregnant, decaf can preserve the polyphenol benefits without the same stimulant load [7-9].
Score · Caffeine itself, not the whole cup of coffee
- As an alertness or exercise tool: Effectiveness 3 · Safety 4 · Evidence 4 · Practicality 5 → ★★★ 🟢 (The immediate benefits are real.)
- As an "anti-aging longevity molecule": Effectiveness 1 · Evidence 2 → 🟡 (The longevity credit belongs to polyphenols, not caffeine.)
Theobromine: Not Much of a Longevity Molecule
Chocolate makes people feel good, and many assume caffeine is responsible. Cocoa actually contains far more theobromine—a close chemical relative of caffeine that acts more weakly but for longer, with much lower stimulant and addictive potential 10. It mildly dilates blood vessels and has weak diuretic and bronchodilator effects 11.
Evidence for health benefits from theobromine itself is thin 11. Cocoa's strongest case still rests on flavanols, its polyphenols. Positive cardiovascular and cognitive signals in large cocoa-flavanol trials are attributed mainly to those compounds 11. Theobromine is better understood as one element of chocolate's distinctive sensory effect than as a longevity molecule. Whether cocoa or chocolate as a whole is healthy—and how much comes from flavanols versus theobromine—deserves a separate calculation, which we will save for another entry.
One practical warning: theobromine is toxic to dogs and cats because they metabolize it slowly. If you have pets, keep the chocolate out of reach 11.
Score · Theobromine
- Effectiveness 1 · Safety 3 (toxic to pets) · Evidence 1 · Practicality 3 → ★ 🟡 (Cocoa's value lies in flavanols, not theobromine.)
Capsaicin: Triggering Our Capacity for Pain
First, a basic correction: spicy is not a taste. Your tongue does not taste heat. Capsaicin activates a receptor on sensory nerves called TRPV1 12, whose real job is to detect burning and pain. Capsaicin fools it, and the brain concludes that your mouth is on fire. The burn is, fundamentally, a pain signal.
The next step is the key—and the reason people describe the response as inflammatory. Once TRPV1 is activated, calcium rushes into nerve endings and triggers release of two neuropeptides: substance P and CGRP, or calcitonin gene-related peptide 13. They produce the familiar vasodilation, flushed face, and sweating. Medicine calls this neurogenic inflammation: a brief inflammatory-like response driven by nerve endings rather than immune cells 14. Calling spicy food "a very small inflammatory-like stress" therefore has a clear neuropeptide pathway behind it.
The elegant part is that the stress is controlled, reversible, and desensitizing—an excellent fit for hormesis. With repeated exposure, TRPV1 becomes less sensitive. The same chili feels milder, and pain declines 13. Medicine has turned this desensitization into a treatment: high-concentration capsaicin patches used for neuropathic pain first deliver an intense stimulus, then functionally desensitize the nerve ending and reduce pain 15.
Animal work sketches an intriguing set of metabolic and vascular adaptations. After capsaicin activates TRPV1, the CaMKII → AMPK → SIRT1 → PGC-1α pathway promotes "browning" of white fat and raises the thermogenic protein UCP1 16. TRPV1 can also connect to eNOS, increasing nitric oxide and improving endothelial function 17. The two neuropeptides themselves dilate blood vessels and may help reduce pressure 13. But we need to be honest about the boundary: most of those mechanisms come from mice and cells. In humans, the most robust results are short-term effects such as greater satiety and reduced food intake 18. A trial of a single dose failed to raise thermogenesis, suggesting that any meaningful effect may require sustained, regular intake 19.
At the population level, cohort findings point in a consistent direction. People who regularly eat chili have about 13%–23% lower all-cause mortality, depending on population and intake, along with lower cardiovascular mortality. Large cohorts in China, Italy, and the United States have all reported similar associations [20-22]. These remain observational associations. A taste for spicy food travels with regional cuisine, overall diet, and lifestyle, so causality—and the ideal level of heat—remains unsettled.
What about dose? This is where capsaicin becomes especially appealing. Its subjectively intense burn is almost a perfect built-in brake. Once food gets hot enough, you instinctively set down the chopsticks and reach for water, making it difficult to eat a genuinely damaging amount. The intensity protects you from excess. It is the kind of bodily feedback loop we have praised throughout this series. The intakes associated with benefit in cohorts are easy for habitual chili eaters to reach and do not require force-feeding yourself for a "therapeutic" dose [20-22]. Dose is therefore an advantage here, not a weakness: a low threshold for exposure paired with a natural upper limit.
There are boundaries. High doses can relax the lower esophageal sphincter and irritate the gastrointestinal tract. If you have reflux, irritable bowel syndrome, a gastric ulcer, or hemorrhoids, spicy food may worsen symptoms and deserves restraint. A myth worth correcting: chili is not the primary cause of gastric ulcers—H. pylori is—and moderate habitual intake may even offer some mucosal protection 19. Capsaicin weight-loss capsules, meanwhile, discard the burn that provides the most useful warning. They deliver an irritating dose directly to the gut, bypass the sensory brake, and have nowhere near enough evidence to support the marketing claims 18,19.
The conclusion is straightforward: the mechanism is clear and the observational signal is favorable, but human evidence has not progressed beyond that level. If you enjoy chili and tolerate it, it is a reasonable habit. If your gut objects, ease off. Skip the weight-loss capsules.
Score · Capsaicin
- Food (chili peppers or a spicy diet): Effectiveness 3 · Safety 4 · Evidence 2 · Practicality 5 → ★★★ 🟡 (A good habit, not a drug.)
- Supplement (capsaicin weight-loss capsules): insufficient human evidence and a gut-irritating dose → 🟡 (Do not count on it for weight loss.)
Nicotine: The Ultimate Cautionary Tale
Alkaloids need a place for nicotine. It is a superb case study in how hormesis works—and an intervention nobody should copy.
Epidemiology has long presented researchers with a puzzle: smokers have a substantially lower risk of Parkinson's disease 23. In animal models, nicotine acting through specific receptors does generate signals consistent with protection of dopamine neurons 24. It sounds like a classic low-dose hormesis story.
Then the story fails in humans. Trials in Parkinson's disease have not shown a therapeutic benefit from nicotine 25. Cognitive studies find only small, short-lived improvements in attention 26. The costs, by contrast, are concrete: powerful addiction, a clear cardiovascular burden, and a very narrow dosing window 27. A molecule with a theoretical hint of benefit but an addictive potential that overwhelms everything else has no place in health advice.
Its real value is conceptual. A stimulating mechanism and an intervention fit for human use are two different things. We will meet that lesson again later in the series when we discuss low-dose heavy metals.
Score · Nicotine
- Effectiveness 2 · Safety 1 (addiction plus cardiovascular risk) · Evidence 2 · Practicality 1 → ★ 🔴
Next we turn to terpenoids and other bitter compounds—bitter melon, milk thistle, and ginseng. Their reputations in traditional use stand well ahead of their clinical performance, making them a useful lesson in the distance between fame and evidence.
References27
[1]Nathanson JA. Caffeine and related methylxanthines: possible naturally occurring pesticides. Science. 1984 Oct;226(4671):184-7.
[2]Steppuhn A, Gase K, Krock B, Halitschke R, Baldwin IT. Nicotine's defensive function in nature. PLoS Biol. 2004 Aug;2(8):E217.
[3]Tewksbury JJ, Nabhan GP. Seed dispersal. Directed deterrence by capsaicin in chilies. Nature. 2001 Jul;412(6845):403-4.
[4]Ding M, Satija A, Bhupathiraju SN, Hu Y, Sun Q, Han J, Lopez-Garcia E, Willett W, van Dam RM, Hu FB. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 2015 Dec;132(24):2305-15.
[5]Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999 Mar;51(1):83-133.
[6]Grgic J, Grgic I, Pickering C, Schoenfeld BJ, Bishop DJ, Pedisic Z. Wake up and smell the coffee: caffeine supplementation and exercise performance—an umbrella review of 21 published meta-analyses. Br J Sports Med. 2020 Jun;54(11):681-8.
[7]McLellan TM, Caldwell JA, Lieberman HR. Caffeine's effects on physical and cognitive performance, mood, and sleep. Neurosci Biobehav Rev. 2016 Dec;71:294-312.
[8]Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017 Nov;359:j5024.
[9]Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018 Apr;70(2):384-411.
[10]Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl). 2013 Jul;228(1):109-18.
[11]Martínez-Pinilla E, Oñatibia-Astibia A, Franco R. The relevance of theobromine for the beneficial effects of cocoa consumption. Front Pharmacol. 2015 Feb;6:30.
[12]Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997 Oct;389(6653):816-24.
[13]Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988 Mar;24(3):739-68.
[14]Chiu IM, von Hehn CA, Woolf CJ. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci. 2012 Jul;15(8):1063-7.
[15]Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P, Rauck R, Tobias J. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol. 2008 Dec;7(12):1106-12.
[16]Baskaran P, Krishnan V, Ren J, Thyagarajan B. Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms. Br J Pharmacol. 2016 Aug;173(15):2369-89.
[17]Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab. 2010 Aug;12(2):130-41.
[18]Whiting S, Derbyshire EJ, Tiwari B. Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data. Appetite. 2014 Feb;73:183-8.
[19]Panchal SK, Bliss E, Brown L. Capsaicin in metabolic syndrome. Nutrients. 2018 May;10(5):630.
[20]Chopan M, Littenberg B. The association of hot red chili pepper consumption and mortality: a large population-based cohort study. PLoS One. 2017 Jan;12(1):e0169876.
[21]Lv J, Qi L, Yu C, Yang L, Guo Y, Chen Y, Bian Z, Sun D, Du J, Ge P, Tang Z, Hou W, Li Y, Chen J, Chen Z, Li L. Consumption of spicy foods and total and cause specific mortality: population based cohort study. BMJ. 2015 Aug;351:h3942.
[22]Bonaccio M, Di Castelnuovo A, Costanzo S, et al. Chili pepper consumption and mortality in Italian adults. J Am Coll Cardiol. 2019 Dec;74(25):3139-49.
[23]Ritz B, Lee PC, Lassen CF, Arah OA. Parkinson disease and smoking revisited. Neurology. 2014 Oct;83(16):1396-402.
[24]Quik M, Parameswaran N, McCallum SE, Bordia T, Bao S, McCormack A, Kim A, Tyndale RF, Langston JW, Di Monte DA. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. J Neurochem. 2006 Sep;98(6):1866-75.
[25]Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov Disord. 2012 Jul;27(8):947-57.
[26]Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 2010 Jul;210(4):453-69.
[27]Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun;362(24):2295-303.
